Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas

• Published in: Oncogene Vol. 38; no. 46; pp. 7113 - 7132
• Main Authors: Yang, Cuixia, Cao, Manlin, Liu, Yiwen, He, Yiqing, Du, Yan, Zhang, Guoliang, Gao, Feng
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.11.2019; Nature Publishing Group
• Subjects: 38; 38/1; 38/35; 38/39; 38/77; 631/67/1347; 631/67/322; 64; 64/60; 96/10; 96/31; Animals; Apoptosis; Breast cancer; Breast carcinoma; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cancer; Carcinoma - metabolism; Carcinoma - pathology; CD44 antigen; Cell Biology; Cell migration; Cell Movement - physiology; Female; Human Genetics; Humans; Hyaluronan Receptors - metabolism; Internal Medicine; Invasiveness; Medicine; Medicine & Public Health; Mesenchyme; Metastases; Metastasis; Mice; Neoplasm Invasiveness - pathology; Oncology; Oncology, Experimental; Phenotypes; Stem cells; Tumors; Japan
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/s41388-019-0899-y

Collective invasion into adjacent tissue is a hallmark of luminal breast cancer, and ~20% of these cases eventually undergo metastasis. How less aggressive luminal-like breast cancer transitions to invasive cancer remains unclear. Our study revealed that CD44 hi cancer cells are the leading subpopulation in collectively invading luminal cancer cells and efficiently promote the collective invasion of CD44 lo /follower cells. The CD44 hi /leader subpopulation showed a specific gene signature of various hybrid epithelial/mesenchymal genes and key functional coregulators of collective invasion, which was distinct from that of CD44 lo /follower cells. However, the CD44 hi /leader cells, which showed a partial epithelial–mesenchymal transition (EMT) phenotype, readily switched to the CD44 lo phenotype along with collective migration and vice versa; this phenomenon was spontaneous and sensitive to the tumor microenvironment. The CD44 lo -to-CD44 hi conversion was accompanied by a shift in CD44s to CD44v but not a conversion of non-cancer stem cells to cancer stem cells (CSCs). Therefore, the CD44 hi leader cells, as currently identified, are not a stable subpopulation in breast tumors. This plasticity and ability to generate CD44 hi carcinoma cells with enhanced migratory and invasive behavior might be responsible for the transition from in situ to invasive behavior of luminal-type breast cancer.